Patent Protection and Bypass Continuation Applications: Evaluating Benefits and Risks, Navigating Priority
A live 90-minute premium CLE video webinar with interactive Q&A
This CLE webinar will guide patent counsel on the use of bypass continuation applications. The panel will discuss the advantages of using the application along with the potential risks. The panel will also offer best practices for using the bypass application and navigating the process.
- Bypass application
- Potential risks
- Bypass traps
- Navigating the process
- Best practices for using the bypass application
The panel will review these and other key issues:
- What are the benefits of and reasons to use the bypass continuation applications?
- What are the potential risks of filing a bypass application?
- What factors should patent practitioners consider when determining whether to use a bypass application?
Rebecca M. McNeill
Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S.... | Read More
Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S. and foreign), and preparation and negotiation of IP transactions, and provides the full scope of counseling services. She has a special interest in counseling clients on patent application filing and developing worldwide prosecution strategies in concert with clients’ business goals. She has managed and directed the U.S. and international patent portfolios for U.S. clients and has overseen the U.S. patent portfolio for international clients in Europe and Asia.Close
Nicholas J. Landau, Ph.D.
Bradley Arant Boult Cummings
Mr. Landau advises clients in the procurement, protection, and litigation of all forms of intellectual property,... | Read More
Mr. Landau advises clients in the procurement, protection, and litigation of all forms of intellectual property, including patents, trademarks, and trade secrets. He is exceptionally experienced in patent prosecution, having drafted over 150 patent applications in numerous technology areas. His patent prosecution experience includes multiple successful ex parte appeals. Mr. Landau has worked with patents in a broad array of technological disciplines and has extensive knowledge in biotechnology, pharmaceuticals, nutraceuticals, medical devices, and environmental technology. His clients include individuals, universities, startups, growing businesses, and publicly traded companies. Mr. Landau’s practice also includes managing sizeable international patent portfolios and coordinating intellectual property strategy at the multinational level. This often includes surrounding core assets with secure intellectual property protection by integrating patents, industrial designs, trade secrets, copyrights, and plant variety protection. He advises clients on their freedom to operate new products and services in light of the intellectual property rights of others and how to avoid liability for infringing others’ rights.Close
Lisa L. Mueller, J.D., B.S.
For over 25 years, Ms. Mueller has provided strategic counsel on complex patent issues to clients in the... | Read More
For over 25 years, Ms. Mueller has provided strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology, and chemistry sectors. She brings in-depth knowledge and extensive experience to her work, advising clients on the global patent protection, freedom to operate, and validity of blockbuster drugs they aim to produce and distribute. With a background in chemistry and biology, she provides advice on the full spectrum of global intellectual property portfolio management, including patent prosecution, opposition, and other post-grant proceedings, and diverse regulatory matters. Since 2001, she has worked closely with in-house legal departments of global pharmaceutical firms regarding their patent development and enforcement strategies. In this partnership, Ms. Mueller provides training to new in-house counsel. She meets with scientists and other business development to anticipate and resolve a wide array of problems, including navigation of FDA approval. A thought leader on pharmaceutical and biopharmaceutical patent law, Ms. Mueller frequently speaks to legal and industry groups and publishes widely.Close
Early Discount (through 10/08/21)
Cannot Attend November 2?
Early Discount (through 10/08/21)
You may pre-order a recording to listen at your convenience. Recordings are available 48 hours after the webinar. Strafford will process CLE credit for one person on each recording. All formats include course handouts.